deoxyepinephrine has been researched along with Obesity in 1 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decara, JM | 1 |
| Pavón, FJ | 1 |
| Suárez, J | 1 |
| Romero-Cuevas, M | 1 |
| Baixeras, E | 1 |
| Vázquez, M | 1 |
| Rivera, P | 1 |
| Gavito, AL | 1 |
| Almeida, B | 1 |
| Joglar, J | 1 |
| de la Torre, R | 1 |
| Rodríguez de Fonseca, F | 1 |
| Serrano, A | 1 |
1 other study available for deoxyepinephrine and Obesity
| Article | Year |
|---|---|
Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.
Topics: Adiposity; Animals; Body Weight; Deoxyepinephrine; Ether-A-Go-Go Potassium Channels; Feeding Behavio | 2015 |